|
47
|
151
|
4uofA |
Crystallographic structure of nucleoside diphosphate kinase from litopenaeus vannamei complexed with dadp |
|
18
|
117
|
4wk1A |
Crystal structure of staphylococcus aureus psta in complex with c-di-amp |
|
18
|
61
|
4w4mA |
Crystal structure of prgk 19-92 |
|
137
|
394
|
4uuxA |
Competence or damage-inducible protein cina from thermus thermophilus |
|
49
|
211
|
4xakA |
Crystal structure of potent neutralizing antibody m336 in complex with mers co-v rbd |
|
76
|
247
|
4wwsA |
Structure of chlorite dismutase-like protein from listeria monocytogenes |
|
24
|
121
|
4ushA |
Nitrogen regulatory protein pii from chlamydomonas reinhardtii in unliganded state |
|
110
|
314
|
4wtyA |
Structure of the ptp-like myo-inositol phosphatase from selenomonas ruminantium in complex with myo-inositol-(1,3,4,5)-tetrakisphosphate |
|
53
|
191
|
4wp3A |
Crystal structure of adenylyl cyclase from mycobacterium avium ma1120 wild type |
|
17
|
111
|
4wk3A |
Structure of staphyloccus aureus psta |
|
34
|
134
|
4uzcA |
Kshv lana (orf73) c-terminal domain, spiral: hexagonal crystal form |
|
134
|
467
|
4uswA |
Crystal structure of human soluble adenylyl cyclase with atp |
|
77
|
224
|
4x84A |
Crystal structure of ribose-5-phosphate isomerase a from pseudomonas aeruginosa |
|
52
|
162
|
4ursA |
Crystal structure of ggdef domain from t.maritima |
|
53
|
182
|
4wxoA |
Sadc (300-487) from pseudomonas aeruginosa pao1 |
|
153
|
478
|
4wylA |
Mutant k18e of 3d polymerase from foot-and-moth disease virus |
|
49
|
171
|
4wp9A |
Crystal structure of adenylyl cyclase ma1120 from mycobacterium avium bound to 2'5'-dd-3'-atp, calcium and magnesium ion |
|
115
|
345
|
4utgA |
Burkholderia pseudomallei heptokinase wcbl,amppnp (atp analogue) complex. |
|
56
|
165
|
4wxwA |
Sadc (323-487) from pseudomonas aeruginosa pao1 |
|
146
|
462
|
4wfyA |
Coxsackievirus b3 polymerase - f232l mutant - amso4 crystal form |
|
165
|
779
|
4uw2A |
Crystal structure of csm1 in t.onnurineus |
|
52
|
154
|
4urqU |
Crystal structure of ggdef domain (i site mutant) from t.maritima |
|
25
|
122
|
4usiA |
Nitrogen regulatory protein pii from chlamydomonas reinhardtii in complex with mgatp and 2-oxoglutarate |
|
50
|
171
|
4wp8A |
Crystal structure of adenylyl cyclase ma1120 from mycobacterium avium in complex with 2'5'-dd-3'-atp and manganese ion |
|
146
|
462
|
4wfzA |
Coxsackievirus b3 3dpol rna dependent rna polymerase - nacl crystal form |
|
194
|
562
|
4tybA |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
|
17
|
84
|
4tnoA |
Hypothetical protein pf1117 from pyrococcus furiosus: structure solved by sulfur-sad using swiss light source data |
|
45
|
143
|
4s0mA |
Crystal structure of nucleoside diphosphate kinase at 1.92 a resolution from acinetobacter baumannii |
|
155
|
402
|
4uf4A |
Crystal structure of the human carboxypeptidase a1 in complex with a thiirane mechanism-based inhibitor |
|
188
|
562
|
4ty9A |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
|
138
|
554
|
4rw7A |
Crystal structure of hiv-1 reverse transcriptase (k103n, y181c) variant in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor |
|
138
|
554
|
4rw9A |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor |
|
19
|
113
|
4rwwA |
Crystal structure of l. monocytogenes psta in complex with cyclic-di-amp |
|
102
|
424
|
4rw7B |
Crystal structure of hiv-1 reverse transcriptase (k103n, y181c) variant in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor |
|
110
|
424
|
4rw4B |
Crystal structure of hiv-1 reverse transcriptase (k103n,y181c) variant in complex with (e)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj494), a non-nucleoside inhibitor |
|
208
|
566
|
4tn2A |
Ns5b in complex with lactam-thiophene carboxylic acids |
|
146
|
554
|
4rw6A |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with (e)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj494), a non-nucleoside inhibitor |
|
161
|
464
|
4rubA |
A crystal form of ribulose-1,5-bisphosphate carboxylase(slash)oxygenase from nicotiana tabacum in the activated state |
|
192
|
562
|
4ty8B |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
|
136
|
548
|
4rw8A |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor' |
|
191
|
562
|
4txsA |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
|
109
|
424
|
4rw9B |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor |
|
111
|
424
|
4rw6B |
Crystal structure of hiv-1 reverse transcriptase (y181c) variant in complex with (e)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj494), a non-nucleoside inhibitor |
|
192
|
616
|
4tktA |
Streptomyces platensis isomigrastatin ketosynthase domain mgsf ks6 |
|
110
|
427
|
4rw8B |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-chloro-5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj532), a non-nucleoside inhibitor' |
|
208
|
785
|
4tvaB |
Universal pathway for post-transfer editing reactions: insight from crystal structure of tthphers with puromycine |
|
188
|
562
|
4ty8A |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
|
20
|
109
|
4rwxA |
Crystal structure of l. monocytogenes psta |
|
40
|
147
|
4u9rA |
Structure of the n-terminal extension from cupriavidus metallidurans czcp |
|
194
|
562
|
4tyaA |
An ligand-observed mass spectrometry-based approach integrated into the fragment based lead discovery pipeline |
